Guardant Health, Inc. GH
Set alert
175.69 USD +4.96 +2.90%
As of Nov 3, 2:43 PM ET
167.31 Day range 178.38
78.60 52-week range 187.22
- YTD
- +72.01%
- 1 year
- +77.61%
- Open
- 172.96
- Prev close
- 170.73
- Mkt cap
- 23.58B
- Vol
- 1.12M
- Avg vol
- 1.90M
- EPS
- -3.50
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 167.31
- High
- 178.38
- Forward P/E
- -450.27
- Beta
- 1.66
- Short ratio
- 6.12
- Inst. own
- 103.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 169.71
- 200-d avg
- 130.50
- 1y target
- 202.24
5Y chart
Events in this range
- Jul 30, 2025Earnings: -0.8; estimate -0.74051; surprise -8.03%
- Oct 29, 2025Earnings: -0.74; estimate -0.78962; surprise 6.28%
- Feb 19, 2026Earnings: -1; estimate -0.76677; surprise -30.42%
- May 7, 2026Earnings: -0.85; estimate -0.806; surprise -5.46%
- Jul 30, 2026Earnings: -0.9; estimate -0.76183; surprise -18.14%
- Sep 9, 2026Rating: UBS · Buy → Buy
- Oct 1, 2026Rating: Guggenheim · Buy → Buy
- Oct 7, 2026Rating: Barclays · Overweight → Overweight
- Oct 13, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 23, 2026Rating: Roth Capital · — → Buy
- Oct 27, 2026Rating: BTIG · Buy → Buy
- Nov 5, 2026Earnings: —; estimate -0.75; surprise —%
Signals (91)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 7, 2026 | 1 month ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jun 22, 2026 | 4 months ago |
| RSI: Overbought | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| RSI: Overbought | Oct 27, 2025 | 1 year ago |
| RSI: Overbought | Aug 25, 2025 | 1 year ago |
Newest 20 of 91.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 202.24 +15.1% upside
Now 175.69
- Target (low)
- 105.00
- Target (mean)
- 202.24
- Target (high)
- 240.00
Ratings (0m) 26 25 buy · 0 hold · 1 sell
- Strong buy4
- Buy21
- Hold0
- Sell0
- Strong sell1
Recommendation trend
- This month 26
- 1 month ago 26
- 2 months ago 25
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31444 | -0.39 – -0.22 | -0.39 | +19.4% | 350.64M | +32.2% | 17 |
| Next quarter | -0.27901 | -0.57011 – -0.17 | -0.50 | +44.2% | 369.15M | +31.2% | 17 |
| Current year | -1.45 | -1.81 – -1.18 | -1.82 | +20.5% | 1.36B | +38.4% | 21 |
| Next year | -0.37917 | -1.43 – 0.7236 | -1.45 | +73.8% | 1.84B | +35.2% | 19 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 23, 2026 | Roth Capital | Initiated | — | Buy |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 9, 2026 | UBS | Maintained | Buy | Buy |
| Sep 8, 2026 | Rothschild & Co | Initiated | — | Buy |
| Sep 2, 2026 | BTIG | Reiterated | Buy | Buy |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 3, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 31, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 31, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 14, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 9, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 8, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 6, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 2, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jul 1, 2026 | BTIG | Maintained | Buy | Buy |
| Jun 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 11, 2026 | RBC Capital | Initiated | — | Outperform |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | Outperform |